In Vitro Analysis of Proliferating CD4+ T Cells in Patients with Rheumatoid Arthritis as a Possible Predictable Marker of TNF-alpha Blockers

Publisher： Bentham Science Publishers

ISSN： 2212-7038

Source： Clinical Anti-Inflammatory & Anti-Allergy Drugs, Vol.1, Iss.1, 2014-04, pp. : 32-38

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenetics of anti-TNF treatment in patients with rheumatoid arthritis

By Coenen Marieke JH Toonen Erik JM Scheffer Hans Radstake Timothy RDJ Barrera Pilar Franke Barbara

Pharmacogenomics, Vol. 8, Iss. 7, 2007-07 ,pp. : 761-773

Future Medicine

Access to resources Recommend Favorite

Increased Soluble CD4 Molecules and the Role of Soluble CD4 Production in Patients with Rheumatoid Arthritis

By Ohkubo T Takei M Mitamura K Horie T Fujiwara S Shimizu K Ryu J Shiraiwa H Sawada S

The Journal of International Medical Research, Vol. 29, Iss. 6, 2001-11 ,pp. : 488-496

Field House Publishing

Access to resources Recommend Favorite

TNF- inhibitors and rheumatoid arthritis

By Shire M.G. Muller G.W.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 5, 1998-05 ,pp. : 531-544

Informa Healthcare

Access to resources Recommend Favorite

Leflunomide induces immunosuppression in collagen-induced arthritis rats by upregulating CD4⁺CD25⁺ regulatory T cells

By Wang Ting-Yu Li Jun Li Chang-Yu Jin Yong Lü Xiong-Wen Wang Xiao-Hua Zhou Qian

Canadian Journal of Physiology and Pharmacology, Vol. 88, Iss. 1, 2010-01 ,pp. : 45-53

NRC Research Press

Access to resources Recommend Favorite

Anti-TNF Treatment in Rheumatoid Arthritis

Current Pharmaceutical Design, Vol. 17, Iss. 29, 2011-10 ,pp. : 3141-3151

Bentham Science Publishers

Access to resources Recommend Favorite